de-DEen-US
Skip to main content
Resources for psychedelic research and consciousness expansion (LSD derivatives)

Scientific Research

Significance and Potential of Psychedelics in Science

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

Abstract

Prospective 12-month follow-up of psilocybin-assisted therapy for major depressive disorder showed sustained antidepressant effects, with response rates maintained at 75% and remission rates at 58% at 12 months post-treatment.

Keywords

psilocybindepressionlong-term follow-up12-monthMDD
Clinical Research